TP53 and cancer: The involvement of FR in folate-induced JAK–STAT3 signaling is often activated in cancers of epithelial origin, promotes proliferation, and is associated with poor patient outcomes (24, 25); it also promotes signaling of the serine/threonine kinases, ERK1 and ERK2 (MAP kinase)/P53 in colorectal cancer tumor cells (26).